TABLET A TO Z MULTIVITAMIN,SYRUP ZINCOVIT,CAPSULE ARISTOZYME,TABLET AMLODEPIN 5 MG,TABLET METFORMIN
Border Security Force (bsf)
KANKER, CHHATTISGARH
Bid Publish Date
06-Nov-2024, 10:08 am
Bid End Date
27-Nov-2024, 11:00 am
Progress
Quantity
426121
Category
TABLET
Bid Type
Two Packet Bid
Public procurement opportunity for Indian Army TABLET, CAPSULE, SYRUP, EYE DROP, INJECTION, MDI, INSULIN, VACCINE, VIAL, OINTMENT, ROCATAP, NASAL DROP, CONSUMABLES. Quantity: 426121 issued by. Submission Deadline: 27-11-2024 11: 00: 00. View full details and respond.
Main Document
BOQ
BOQ
GEM_GENERAL_TERMS_AND_CONDITIONS
Border Security Force (bsf)
KANKER, CHHATTISGARH
Indian Army
TINSUKIA, ASSAM
Rani Lakshmi Bai Central Agricultural University
JHANSI, UTTAR PRADESH
Indian Air Force
Border Security Force (bsf)
DARJEELING, WEST BENGAL
Tender Results
Loading results...
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) |
|---|---|---|---|---|---|---|
| 1 | TABLET | ACARBOSE 50MG TAB | 4,500 | no | neeleshpatel.206w | 21 |
| 2 | TABLET | N-ACETYL CYSTEINE 600 MG TAB | 2,100 | no | neeleshpatel.206w | 21 |
| 3 | CAPSULE | ALFACALCIDOL VIT D 3 0.25MCG CAP | 9,600 | no | neeleshpatel.206w | 21 |
| 4 | TABLET | AMIODARONE HCL 200 MG TAB | 1,200 | no | neeleshpatel.206w | 21 |
| 5 | TABLET | S-AMLODEPINE 5 MG TAB | 33,000 | no | neeleshpatel.206w | 21 |
| 6 | TABLET | AMOXYCILLIN 875 MG PLUS CLAVALUNIC ACID 125 MG TAB | 1,050 | no | neeleshpatel.206w | 21 |
| 7 | SYRUP | ANTACID GEL EACH 5ML CONTAINING DRIED ALUMINIUM HYDROXIDE GEL IP 250MG MAGNESIUM HYDROXIDE NF 250MG AND METHYL POLYSILOXANE 50MG BOTTLE OF 170 ML | 530 | bott | neeleshpatel.206w | 21 |
| 8 | TABLET | TAB APIXABAN 2.5 MG | 500 | no | neeleshpatel.206w | 21 |
| 9 | TABLET | TAB APIXABAN 5MG | 600 | no | neeleshpatel.206w | 21 |
| 10 | TABLET | ASPRIN 75MG TAB | 32,500 | no | neeleshpatel.206w | 21 |
| 11 | TABLET | CARVEDILOL 12.5MG TAB | 750 | no | neeleshpatel.206w | 21 |
| 12 | TABLET | CLOPIDOGREL 75MG TAB | 11,800 | no | neeleshpatel.206w | 21 |
| 13 | TABLET | CYPROHEPTADINE 4MG TAB | 2,000 | no | neeleshpatel.206w | 21 |
| 14 | CAPSULE | DABIGATRAN ETEXILATE 110MG CAPSULE | 600 | no | neeleshpatel.206w | 21 |
| 15 | TABLET | TAB DAPAGLIFLOZIN 10MG | 10,200 | no | neeleshpatel.206w | 21 |
| 16 | TABLET | DIVALPROATE 500 MG TAB | 500 | no | neeleshpatel.206w | 21 |
| 17 | EYE DROP | DORZOLAMIDE 2 PER EYE DROPS | 21 | bott | neeleshpatel.206w | 21 |
| 18 | EYE DROP | TRAVOPROST 0.004 PERCENTAGE WITH POLYQUARD 0.001PERCENTAGE BOTT OF 2.5 ML EYE DROPS | 25 | bott | neeleshpatel.206w | 21 |
| 19 | TABLET | ELTROMBOPAG 25MG TAB | 90 | no | neeleshpatel.206w | 21 |
| 20 | TABLET | TAB EMPAGLIFLOZIN 10 MG | 900 | no | neeleshpatel.206w | 21 |
| 21 | TABLET | ETOPHYLLINE 115 MG AND THEOPHYLLINE 35 MG IN SLOW RELEASE FORM TAB | 5,000 | no | neeleshpatel.206w | 21 |
| 22 | TABLET | TAB ETORICOXIB 90MG | 2,700 | no | neeleshpatel.206w | 21 |
| 23 | TABLET | FEBUXOSTAT 40MG TAB | 10,900 | no | neeleshpatel.206w | 21 |
| 24 | TABLET | HEAMATINIC TAB/CAP CONTAINING (A) FERROUS FUMARATE WITH 100 MG ELEMENTAL IRON (B) FOLIC ACID 500 MCG - 1500 MCG | 12,600 | no | neeleshpatel.206w | 21 |
| 25 | TABLET | FEXOFENADINE 180 MG TAB | 400 | no | neeleshpatel.206w | 21 |
| 26 | TABLET | FRUSEMIDE 20MG PLUS SPIRONOLACTONE 50MG TAB | 1,010 | no | neeleshpatel.206w | 21 |
| 27 | TABLET | FOLIC ACID 5 MG TAB | 6,500 | no | neeleshpatel.206w | 21 |
| 28 | TABLET | GLICLAZIDE XR 60 MG TAB | 3,000 | no | neeleshpatel.206w | 21 |
| 29 | TABLET | HYDROXYCHLOROQUINE 200 MG TAB | 5,000 | no | neeleshpatel.206w | 21 |
| 30 | INJECTION | HYOSCINE BROMIDE INJ 20MG/ML 1 ML INJ | 20 | amp | neeleshpatel.206w | 21 |
| 31 | TABLET | INDAPAMIDE SR /MODIFIED RELEASE /PROLONGED RELEASE /CONTROLLED RELEASE 1.5 MG TAB/ CAP | 6,300 | no | neeleshpatel.206w | 21 |
| 32 | MDI | SALMETEROL 25 MCG PLUS FLUTICASONE 125 MCG 120 DOSES (MDI) | 75 | no | neeleshpatel.206w | 21 |
| 33 | INJECTION | INJ DARBEPOIETIN ALFA (R DNA ORIGIN) 200MCG | 12 | pfs | neeleshpatel.206w | 21 |
| 34 | INSULIN | INSULIN PREMIXED BIPHASIC 40 IU PER ML (30 PERCENTAGE HUMAN NEUTRAL PLUS 70 PERCENTAGE HUMAN ISOPHANE INSULIN) 10 ML INJ | 570 | vial | neeleshpatel.206w | 21 |
| 35 | INJECTION | GOSERLIN 10.8MG INJ | 1 | vial | neeleshpatel.206w | 21 |
| 36 | INJECTION | INJ METHOXY POLYETHYLENE GLYCOL EPOETIN BETA 50 MCG/ 0.3 ML | 3 | no | neeleshpatel.206w | 21 |
| 37 | INJECTION | ONDANSETRON (2MG/ML) 4ML INJ | 20 | amp | neeleshpatel.206w | 21 |
| 38 | VACCINE | PURIFIED VERO CELL RABIES VACCINE | 30 | vial | neeleshpatel.206w | 21 |
| 39 | INJECTION | INJ TERIPARATIDE 750 MCG/3ML | 11 | amp | neeleshpatel.206w | 21 |
| 40 | VIAL | INSULIN HIGHLY PURIFIED HUMAN NEUTRAL 40 IU/ML 10 ML INJ | 150 | amp | neeleshpatel.206w | 21 |
| 41 | TABLET | ITOPRIDE 50 MG | 300 | no | neeleshpatel.206w | 21 |
| 42 | CAPSULE | ITRACONAZOLE 100 MG CAP | 1,200 | no | neeleshpatel.206w | 21 |
| 43 | TABLET | TAB IVABRADINE 5 MG | 1,600 | no | neeleshpatel.206w | 21 |
| 44 | TABLET | MONTELEUKAST 10MG PLUS LEVOCETRIZINE 5MG TAB | 6,300 | no | neeleshpatel.206w | 21 |
| 45 | TABLET | TAB METHYLCOBALAMINE 1500MCG | 16,000 | no | neeleshpatel.206w | 21 |
| 46 | TABLET | TAB METFORMIN 500 MG PLUS TAB VILDAGLIPTIN 50 MG | 5,000 | no | neeleshpatel.206w | 21 |
| 47 | TABLET | METFORMIN SR 0.5GM | 27,000 | no | neeleshpatel.206w | 21 |
| 48 | TABLET | METFORMIN SR 1GM TAB | 20,000 | no | neeleshpatel.206w | 21 |
| 49 | TABLET | TAB METOPROLOL XL 25MG | 15,000 | no | neeleshpatel.206w | 21 |
| 50 | TABLET | MICRONIZED PURIFIED FLAVONOID FRACTION OF RUTACEAE 500 MG TAB | 1,500 | no | neeleshpatel.206w | 21 |
| 51 | OINTMENT | MUPIROCIN 2PER OINT TUBE OF 5 GM | 120 | tube | neeleshpatel.206w | 21 |
| 52 | TABLET | MYCOPHENOLATE MOFETIL 500MG TAB | 1,680 | no | neeleshpatel.206w | 21 |
| 53 | TABLET | MYCOPHENOLATE SODIUM 360 MG TAB | 180 | no | neeleshpatel.206w | 21 |
| 54 | TABLET | NICORANDIL 10 MG TAB | 4,500 | no | neeleshpatel.206w | 21 |
| 55 | TABLET | PHENIRAMINE MALEATE 25MG TAB | 500 | no | neeleshpatel.206w | 21 |
| 56 | TABLET | PRAZOSIN 2.5 MG SUSTAINED RELEASE/SLOW RELEASE TAB | 500 | no | neeleshpatel.206w | 21 |
| 57 | TABLET | CAP PROBIOTIC (MULTIBACILLARY-4) OR MORE ORGANISIMIS) | 450 | no | neeleshpatel.206w | 21 |
| 58 | TABLET | PREGABALIN 75 MG PLUS METHYLCOBALAMINE 1500 MCG TAB | 4,500 | no | neeleshpatel.206w | 21 |
| 59 | TABLET | PREGABALIN 75MG CAP/TABLET | 15,600 | no | neeleshpatel.206w | 21 |
| 60 | TABLET | RAMIPRIL 10MG TAB | 1,000 | no | neeleshpatel.206w | 21 |
| 61 | TABLET | RIVAROXABAN 10 MG TAB | 360 | no | neeleshpatel.206w | 21 |
| 62 | TABLET | RIVAROXABAN 15 MG TAB | 360 | no | neeleshpatel.206w | 21 |
| 63 | TABLET | ROSUVASTATIN 5 MG TAB | 2,400 | no | neeleshpatel.206w | 21 |
| 64 | TABLET | CAP SACCHAROMYCES BOULARDII 250 MG | 300 | no | neeleshpatel.206w | 21 |
| 65 | TABLET | SACUBITRIL 49MG PLUS VALSARTAN 51MG TAB | 1,200 | no | neeleshpatel.206w | 21 |
| 66 | ROCATAP | SALMETEROL 50 MCG PLUS FLUTICASONE 250 MCG PULVERISED FOR INHALATION ROTACAPS PACK OF 30 | 1,010 | no | neeleshpatel.206w | 21 |
| 67 | TABLET | SAROGLITAZAR 4 MG TAB | 350 | no | neeleshpatel.206w | 21 |
| 68 | TABLET | SEMAGLUTIDE 7 MG TAB | 90 | no | neeleshpatel.206w | 21 |
| 69 | TABLET | SILODOSIN 8 MG TAB | 2,100 | no | neeleshpatel.206w | 21 |
| 70 | TABLET | SITAGLIPTIN 100 MG TAB | 900 | no | neeleshpatel.206w | 21 |
| 71 | NASAL DROP | SODIUM CHLORIDE 0.65 PER W/V NASAL DROPS IN 15 ML | 30 | no | neeleshpatel.206w | 21 |
| 72 | EYE DROP | EYE DROP SODIUM HYLURONATE 1MG/ML PRESERVATIVE FREE PHOSPHATE FREE WITH COMOD SYSTEM | 30 | no | neeleshpatel.206w | 21 |
| 73 | TABLET | SPIRONOLACTONE 25MG TAB | 1,000 | no | neeleshpatel.206w | 21 |
| 74 | SYRUP | SUCRALFATE SUSPENSION 1GM/5ML BOTT OF 200ML | 60 | no | neeleshpatel.206w | 21 |
| 75 | SYRUP | LACTULOSE SYP EACH 5ML CONTAINING 3.325G BOTT OF 100 ML | 150 | bott | neeleshpatel.206w | 21 |
| 76 | TABLET | METOPROLOL EXTENDED RELEASE 50MG TAB | 23,000 | no | neeleshpatel.206w | 21 |
| 77 | TABLET | TAMSULOSIN HCL 0.4 MG PROLONGED RELEASE / MODIFIED RELEASE / CAP/TAB | 6,900 | no | neeleshpatel.206w | 21 |
| 78 | TABLET | TELMISARTAN 40 MG TAB | 28,500 | no | neeleshpatel.206w | 21 |
| 79 | TABLET | TELMISARTAN 40 MG PLUS HYDROCHLOROTHIAZIDE 12.5 MG TAB | 4,000 | no | neeleshpatel.206w | 21 |
| 80 | TABLET | TENOFOVIR (300MG) PLUS LAMIVUDINE (300MG) PLUS EFAVIRENZ (600MG) COMBINATION PILL | 180 | no | neeleshpatel.206w | 21 |
| 81 | TABLET | TAB TENOFOVIR 300MG | 90 | no | neeleshpatel.206w | 21 |
| 82 | TABLET | THYROXINE SODIUM 0.1MG TAB | 9,000 | no | neeleshpatel.206w | 21 |
| 83 | TABLET | THYROXINE SODIUM 0.025 MG TAB | 10,500 | no | neeleshpatel.206w | 21 |
| 84 | TABLET | TAB THYROXINE 50 MCG | 9,000 | no | neeleshpatel.206w | 21 |
| 85 | TABLET | TAB TICAGRELOR 90 MG | 1,300 | no | neeleshpatel.206w | 21 |
| 86 | TABLET | TOFACITINIB 5MG TABLET | 1,100 | no | neeleshpatel.206w | 21 |
| 87 | TABLET | TORSEMIDE 10 MG (SCORED TAB) | 5,000 | no | neeleshpatel.206w | 21 |
| 88 | TABLET | METFORMIN 1000 MGPLUSVILDAGLIPTIN 50 MG TAB | 5,000 | no | neeleshpatel.206w | 21 |
| 89 | TABLET | VITAMIN E 200 MG CAP | 1,200 | no | neeleshpatel.206w | 21 |
| 90 | OINTMENT | OINT BETAMETHASONE DIPROPIONATE 0.05PER AND SALICYLIC ACID 3PERTUBE OF 20 GM | 10 | tube | neeleshpatel.206w | 21 |
| 91 | TABLET | CHLORZOXAZONE 500 MG PLUS DICLOFENAC SODIUM 50 MG PLUS PARACETAMOL 325 MG TAB | 600 | no | neeleshpatel.206w | 21 |
| 92 | TABLET | CITICOLINE 500MG TAB | 300 | no | neeleshpatel.206w | 21 |
| 93 | TABLET | DOXYLAMINE SUCCINATE 10MG USP PLUS PYRIDOXINE HYDROCHLORIDE 10MG IP TAB | 58 | no | neeleshpatel.206w | 21 |
| 94 | EYE DROP | CARBOXY METHYL CELLULOSE 1PER EYE DROP BOTT OF 10ML | 50 | bott | neeleshpatel.206w | 21 |
| 95 | EYE DROP | MOXIFLOXACIN 0.5 PERCENT PRESERVATIVE FREE EYE DROPS | 30 | bott | neeleshpatel.206w | 21 |
| 96 | EYE DROP | LEVO-SALBUTAMOL 50 MCG PLUS IPRATROPIUM 20 MCG METERED DOSE INHALER 200 DOSE UNITS | 30 | no | neeleshpatel.206w | 21 |
| 97 | OINTMENT | 011382-KETOCONAZOLE CREAM 2 PER 30G TUBE | 20 | tube | neeleshpatel.206w | 21 |
| 98 | OINTMENT | MOMETASONE 0.1PER TUBE OF 10GM | 30 | tube | neeleshpatel.206w | 21 |
| 99 | TABLET | TAB PARACETAMOL 650 MG | 600 | no | neeleshpatel.206w | 21 |
| 100 | CAPSULE | RIFAXIMIN 550 MG CAP | 60 | no | neeleshpatel.206w | 21 |
| 101 | TABLET | LEVOCARNITINE 500 MG TAB | 3,000 | no | neeleshpatel.206w | 21 |
| 102 | CONSUMABLES | ESR PIPPETE | 40 | no | neeleshpatel.206w | 21 |
| 103 | CONSUMABLES | NEEDLE (ONLY) | 400 | no | neeleshpatel.206w | 21 |
| 104 | CONSUMABLES | DISTILLED WATER(LTR)(strile water) | 4 | ltr | neeleshpatel.206w | 21 |
| 105 | CONSUMABLES | URINE CONTAINER | 200 | nos | neeleshpatel.206w | 21 |
| 106 | CONSUMABLES | AB.COTTON 50GM | 60 | nos | neeleshpatel.206w | 21 |
| 107 | CONSUMABLES | CRAPE BANDAGE 10CM | 30 | nos | neeleshpatel.206w | 21 |
| 108 | CONSUMABLES | INSULIN SYRINGE | 6,000 | nos | neeleshpatel.206w | 21 |
| 109 | CONSUMABLES | LUMBER BELT(M) | 20 | nos | neeleshpatel.206w | 21 |
| 110 | CONSUMABLES | LUMBER SCRAL BELT(XL) | 20 | nos | neeleshpatel.206w | 21 |
| 111 | CONSUMABLES | AB.COTTON 500GM | 30 | nos | neeleshpatel.206w | 21 |
| 112 | CONSUMABLES | LUMBER BELT (L) | 20 | nos | neeleshpatel.206w | 21 |
| 113 | CONSUMABLES | SLIDE MICROSCOPIC GLASS | 300 | box of 50 | neeleshpatel.206w | 21 |
| 114 | CONSUMABLES | MICROTIPS 100 MICROML | 200 | nos | neeleshpatel.206w | 21 |
| 115 | CONSUMABLES | SPIRIT (BOTT OF 500ML) | 1 | bott | neeleshpatel.206w | 21 |
| 116 | CONSUMABLES | DISPOSALE TUBE | 200 | nos | neeleshpatel.206w | 21 |
| 117 | TABLET | LOSARTAN 50MG Plus HYDROCHLORTHIAZIDE 12.5MG TAB | 9,000 | no | neeleshpatel.206w | 21 |
Discover companies most likely to bid on this tender
Experience Criteria
Past Performance
Bidder Turnover
Certificate (Requested in ATC)
OEM Authorization Certificate
OEM Annual Turnover
Compliance of BoQ specification and supporting document *In case any bidder is seeking exemption from Experience / Turnover Criteria
the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer
The eligibility requirements include being a registered supplier with a valid GST, compliance with the minimum average annual turnover of ₹3 lakh, and a demonstrated past performance of at least 80%. Suppliers must also have the necessary documentation to apply for MSE exemptions if applicable.
Bidders must submit various certificates including OEM Authorization Certificate, proof of past performance, and compliance documentation as specified in the tender’s ATC. It's crucial to ensure all certificates are up-to-date and meet the specified guidelines.
To register for bidding, prospective suppliers must create an account on the government e-marketplace (GeM) portal. Registration involves providing business information, GST details, and banking information to facilitate payment processes.
Submissions must be made in digitally signed PDF formats as per the requirements outlined in the tender documents. All documents submitted should comply with standards stated in the Bid Submission Guidelines.
The technical specifications required will be detailed within the BoQ document linked to the tender. Bidders must ensure all products comply with the relevant quality standards required for military use.
Yes, all products must meet defined quality standards that align with the regulations governing pharmaceutical and medical products within India. Documentation proving compliance with such standards must be furnished during the bid submission.
Compliance requirements include adhering to all regulatory standards applicable to pharmaceutical supplies, proof of product certifications, and fulfilling any additional compliance criteria specified in the tender.
The Earnest Money Deposit (EMD) required for participating in this tender is a financial guarantee that ensures serious bidding. The specifics regarding the EMD amount will be outlined in the tender documentation.
Post-award of the contract, successful bidders are typically required to furnish a performance security equivalent to a specified percentage of the contract value, ensuring commitment to the delivery terms specified in the contract.
Payment terms are usually defined within the contract clauses following successful delivery and acceptance of goods. It is essential to review the payment schedule outlined in the tender to understand specific timelines for disbursement.
The price evaluation will focus on selecting the bids that offer the lowest price while meeting all stipulated technical requirements. This ensures value for money while upholding quality standards.
Key timelines include submission deadlines specified in the tender documents. It's essential for bidders to track these dates carefully to ensure timely submission of all required documentation.
The results following the bid evaluation process will be communicated through the GeM platform. Bidders are advised to monitor the platform for notifications regarding their submission status.
Yes, Micro, Small, and Medium Enterprises (MSEs) can benefit from exemptions related to experience criteria which facilitate their participation in government tenders, encouraging support for smaller businesses.
Startups may find the submission process more accessible with relaxed compliance requirements. The tender framework is designed to promote innovation and participation from emerging businesses as part of fostering entrepreneurship.
This tender aligns with the ‘Make in India’ initiative by encouraging local sourcing of drugs and consumables as part of government efforts to promote domestic manufacturing, supporting local suppliers in the pharmaceutical and healthcare sectors.
Sign up now to access all documents
Main Document
BOQ
BOQ
GEM_GENERAL_TERMS_AND_CONDITIONS